SCHEMBL29680508

SCHEMBL29680508

CC1(C)OB(c2cccc3cccc(C(F)F)c23)OC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LPL P06858 5/20 0.35
LIPG Q9Y5X9 5/20 0.35
JAK2 O60674 2/20 0.32
BTK Q06187 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29080160 1.00 LPL (0.35) LPLLIPGJAK2BTK
SCHEMBL183904 0.82 LPL (0.42) LPLLIPGJAK2BTK
SCHEMBL29469030 0.82 LPL (0.42) LPLLIPGJAK2BTK
SCHEMBL16637594 0.81 LPL (0.38) LPLLIPGJAK2BTK
SCHEMBL31156286 0.81 JAK2 (0.40) LPLLIPGJAK2BTK
SCHEMBL23043006 0.79 JAK2 (0.41) LPLLIPGJAK2BTK
SCHEMBL29418721 0.79 JAK2 (0.41) LPLLIPGJAK2BTK
SCHEMBL26197525 0.78 LPL (0.33) LPLLIPGJAK2BTK
SCHEMBL23053926 0.78 LPL (0.36) LPLLIPGJAK2BTK
SCHEMBL22208223 0.77 LPL (0.38) LPLLIPGJAK2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4262807-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-10-25 EP disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 WO disclosed